About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
Precise Antibody Engineering
About us
Our Company
Our People
Contact
Home
Our Science
Cytokine-Fusion Antibody
Novel T cell Targets
Precise Antibody Engineering
Partnering with Us
Pipeline
MFA011
MMB101
MMB102
MMB102
Pipeline
News
2024-07-11
MediMabBio Joins KHIDI’s Vaccine Corporate Council
2024-05-24
MediMabBio to Present Groundbreaking Research at EACR2024
2024-04-30
MediMabBio signs MoU with PDC*line Pharma to collaborate on cancer immunotherapy
2024-01-30
MediMabBio Selected for Celltrion’s Open Innovation Program
2023-05-25
MediMabBio Selected for Ministry of SME’s and Startups TIPS Overseas Marketing Funding
2022-01-01
MediMabBio selected as the ‘Best Employer’ by Seongnam City Council
2021-10-28
MediMabBio takes first step towards commercialization with Thermo Fisher CDMO Contract
2021-06-28
MediMabBio has made a collaboration deal with University Hospitals Birmingham for immunotherapy cancer drug development
2021-02-15
MediMabBio has successfully completed a Series-A fundraising with 18 million USD
«
1
2
3
»